Universal Beteiligungs und Servicegesellschaft mbH Buys New Shares in Phibro Animal Health Corporation (NASDAQ:PAHC)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH has acquired 15,477 shares of Phibro Animal Health Corporation (NASDAQ:PAHC), valued at approximately $331,000.
• Phibro Animal Health reported $0.63 EPS for the last quarter, exceeding analyst expectations of $0.52, despite revenue falling short at $347.80 million.
• The company announced a quarterly dividend of $0.12 per share, representing a yield of 1.8%, which is set to be paid on September 24th.

Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 15,477 shares of the company's stock, valued at approximately $331,000.

A number of other large investors have also recently made changes to their positions in PAHC. LPL Financial LLC lifted its position in shares of Phibro Animal Health by 66.9% during the fourth quarter. LPL Financial LLC now owns 87,446 shares of the company's stock valued at $1,836,000 after buying an additional 35,053 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Phibro Animal Health by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company's stock valued at $31,809,000 after purchasing an additional 20,604 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in Phibro Animal Health by 35.6% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 322,090 shares of the company's stock valued at $6,764,000 after acquiring an additional 84,599 shares during the period. Alliancebernstein L.P. raised its position in shares of Phibro Animal Health by 357.1% in the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock valued at $2,730,000 after buying an additional 101,560 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Phibro Animal Health by 1.7% during the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company's stock valued at $10,838,000 after acquiring an additional 8,510 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Up 2.9%

Shares of NASDAQ:PAHC traded up $0.77 during trading on Thursday, reaching $27.26. 128,761 shares of the company traded hands, compared to its average volume of 258,104. The firm has a fifty day simple moving average of $26.86 and a 200 day simple moving average of $23.41. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $31.80. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The firm has a market cap of $1.10 billion, a P/E ratio of 35.01, a price-to-earnings-growth ratio of 0.45 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. Analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.8%. Phibro Animal Health's dividend payout ratio is currently 61.54%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on PAHC shares. JPMorgan Chase & Co. raised Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their price target for the stock from $25.00 to $35.00 in a report on Monday, July 7th. Morgan Stanley set a $26.00 target price on Phibro Animal Health and gave the stock an "equal weight" rating in a research report on Wednesday, June 25th. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target for the company in a research report on Monday, June 16th. Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, BNP Paribas raised Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Phibro Animal Health presently has an average rating of "Hold" and an average price target of $24.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.